ProteoDesign is a Biotech spin-out from Princeton University focused on developing the next-gen cancer immunotherapy and targeted therapies. Our proprietary technology enables precise targeting of dendritic cells in vivo to trigger an innate and adaptive response against cancer.
Products, services and capacities
Personalized cancer immunotherapies
Health & Healthcare Services
Activity classification (NACE)
7219 - Other research and experimental development on natural sciences and engineering